Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pi Research and Development Center is the primary research and development wing of Renata Limited, a prominent pharmaceutical and animal health company based in Bangladesh. The center specializes in the development of generic formulations, including complex dosage forms and value-added medicines for both local and international markets. Located in Dhaka, the facility is equipped with advanced technology for formulation development, analytical method validation, and stability studies. It supports Renata's compliance with international regulatory standards, facilitating exports to regulated markets such as the United Kingdom and the European Union. The center's work spans a wide range of therapeutic areas, including cardiovascular health, oncology, and nutrition. Through its rigorous R&D efforts, the center ensures the delivery of high-quality, affordable healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pi Research and Development Center, Bangladesh.